NetworkNewsBreaks

FridayApr 29, 2022 10:44 am

NetworkNewsBreaks – Arogo Capital Acquisition Corporation (NASDAQ: AOGOU) Enters Agreement with AR/VR, Knowledge Metaverse Company

Arogo Capital Acquisition (NASDAQ: AOGOU), a special purpose acquisition corporation (“SPAC”), has entered into a definitive business combination agreement with EON Reality Inc. With its two decades of experience, EON has built a reputation for being a leader in virtual and augmented reality (“ARVR”) along with knowledge Metaverse industry and education solutions. According to the agreement, the two companies will combine to become a public company named EON Reality Inc., which will be listed on the Nasdaq market exchange. The announcement noted that EON Reality chair and CEO Dan Lejerskar will maintain his position as head of the combined company.…

Continue Reading

ThursdayApr 28, 2022 3:17 pm

NetworkNewsBreaks – Nowigence Inc. Streamlining How Teams Use Intelligence to Make Decisions, Complete Tasks

Nowigence provides a unique solution to the growing challenge of collaboration overload and the desperate need for tools that identify, organize and distribute information in a uniform way to provide access to critical information. The company accomplishes this through its Pluaris offering, which reads and analyzes articles, documents and other textual data, enabling users to learn more in less time, uncover hidden insights, and stay on top of the information they need to know. A recent article, which contains excerpts from Nowigence’s website, reads: “‘Communication is hard, and information is easily lost in translation, leading to duplication of effort in…

Continue Reading

ThursdayApr 28, 2022 3:03 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Unlock Capabilities of Revolutionary DehydraTECH(TM) Platform

Lexaria Bioscience Corp. (NASDAQ: LEXX) is aware of the need to continuously improve its understanding of the capabilities and potential applications of its patented DehydraTECH(TM) drug delivery technology. This informs its long-held commitment to its applied research and development (“R&D”) programs. “So far, the company’s research journey has involved a series of controlled and well-designed in vitro preclinical testing and in vivo animal and human clinical studies…. Still, Lexaria is unrelenting in its pursuit of comprehensive datasets that would answer many questions the company expects to face from potential commercial partners or regulators and is, in fact, expanding its research.…

Continue Reading

ThursdayApr 28, 2022 2:42 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Advancing Pipeline in Commitment to Transform Mental Health Treatment Landscape

Cybin (NYSE American: CYBN) (NEO: CYBN) is a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions in a commitment to transform the mental health treatment landscape. Through its proprietary deuterated process, Cybin is combining controllable drug-delivery systems with novel psychedelic molecules, thus creating patent-protected, commercially scalable drug candidates. “The company currently is moving three of these drug candidates forward: CYB003, CYB004 and CYB005. Cybin’s active drug programs target major depressive disorder (CYB003), alcohol use disorder (CYB003), anxiety disorders (CYB004) and neuroinflammation (CYB005),” reads a recent article. “Cybin recently announced that it commenced a…

Continue Reading

ThursdayApr 28, 2022 1:49 pm

NetworkNewsBreaks – NetworkNewsWire to Serve as Official NewsWire for Full Slate of Finovate 2022 Events

IBN (“InvestorBrandNetwork”), an innovative content distributor and multifaceted communications organization with 50+ brands, today announced that its NetworkNewsWire brand was designated as the official newswire for conferences hosted by Finovate for another full year. IBN will continue to serve as the corporate communications firm for Finovate events. A research and events firm focused on innovation in financial and banking technology, Finovate hosts a full lineup of events, including FinovateEurope, FinovateSpring, FinovateFall, FinovateAwards and FinovateFocus, with content delivered via in-person and virtual formats. Well known for drawing high-level executives and fintech innovators, Finovate conferences feature expert speakers and presenters who offer…

Continue Reading

ThursdayApr 28, 2022 1:45 pm

NetworkNewsBreaks – SPYR Inc. (SPYR) Evaluating Potential IP Acquisitions, Product Line Additions

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company, and its subsidiary, Applied Magix Inc., is exploring potential acquisition opportunities that would expand the company’s essential intellectual property (“IP”) or product lines. Applied Magix develops and resells Apple(R) ecosystem-compatible products in the growing multibillion-dollar smart home and connected car markets, is investigating possible acquisition targets to add essential intellectual property to its line of products, as well as new product lines. According to Applied Magix CEO Dr. Harald Zink, Applied Magix is always on the lookout for new and innovative technologies and has recently identified several potential IP targets that are AI-based and…

Continue Reading

ThursdayApr 28, 2022 1:36 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Approval from Ethics Committee and Competent Authority in Spain for Potentially Pivotal Study

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system (“CNS”). The company today announced its receipt of approval from the Spanish Agency for Medicines and Health Products (“AEMPS”) Competent Authority and from the CElm Provincial de Sevilla Ethics Committee in Spain for CNSP’s potentially pivotal study of Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types of brain cancer. “We continue to build momentum in our potentially pivotal study of Berubicin, and importantly advance toward bringing…

Continue Reading

ThursdayApr 28, 2022 1:29 pm

NetworkNewsBreaks – GreenBox POS (NASDAQ: GBOX) to Participate in Taglich Brothers Conference

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, will be presenting during next month’s Taglich Brothers Investment Conference. The two-day event is scheduled for May 2–3, 2022, and will take place in New York City. GreenBox chair Ben Errez will be presenting during the event. His presentation will include a discussion of the company’s growing customized blockchain-based payment solutions along with an overview of the company’s strategic plans to become an integral presence in the digital payments landscape. Errez’s presentation is slated for May 2 at 4:15 p.m. ET. Taglich Brothers is a full-service brokerage firm specializing in…

Continue Reading

ThursdayApr 28, 2022 1:07 pm

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Signs Deal to Provide Three ASRs to San Francisco Bay Area Client

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, continues to make major progress in its focus on market expansion. The company just announced that a San Francisco Bay Area biotech real estate development will be provided with two of its K5 ASRs and one K1 ASR to enhance the client’s amenity-rich real estate project and underscore the importance of public safety in a highly regulated environment. “Biotech firms, like any other type of business, need to be protected from break-ins, vandalism, and other intrusions,” the company stated in the press release. “Unlike…

Continue Reading

ThursdayApr 28, 2022 12:48 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Patent Portfolio with Novel Cannabinoid Analogs, Initiates Strategic Research Collaboration Agreement

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced the publication of a patent application in North America. The application has broad claims directed to the molecular structure, uses and methods of manufacturing of several cannabinoid analogs. Describing several new cannabinoid-related chemical compounds, the broad patent application, if granted, allows for the creation of several variations of novel cannabinoid compounds, producing a robust library of proprietary new chemical entities (“NCEs”). “We believe rare cannabinoids hold tremendous therapeutic potential that may address a number of unmet medical needs,” said Eric Hsu, SVP,…

Continue Reading